CBDNewsBreaks – Why Willow Biosciences Inc. (CSE: WLLW) Is ‘One to Watch’

Alberta, Canada-based Willow Biosciences (CSE: WLLW) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. A recent article discussing Willow Biosciences reads, “The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins … Continue reading “CBDNewsBreaks – Why Willow Biosciences Inc. (CSE: WLLW) Is ‘One to Watch’”

Video Outlines Benefits of Willow Biosciences Inc.’s (CSE: WLLW) JDA to Develop CBD through Biosynthesis

Canada-based Willow Biosciences and U.S.-based Noramco are teaming to biosynthetically produce and market pharmaceutical-grade cannabidiol (CBD) The companies expect to deliver yeast-cultivated CBD as a low-cost, ultra-pure alternative to cannabis cultivation that avoids large-scale plant waste from greenhouse processes Yeast-grown pharmaceutical ingredients have long served as fodder for insulin and other important drugs; the growing … Continue reading “Video Outlines Benefits of Willow Biosciences Inc.’s (CSE: WLLW) JDA to Develop CBD through Biosynthesis”

Willow Biosciences Inc. (CSE: WLLW) is “One to Watch”

Exclusive joint development agreement with Noramco, the world’s largest producer of chemically synthesized cannabinoids and pharmaceutical APIs, to commercialize biosynthesized CBD Willow is fully funded with $37 million and expects to have more than $15 million on the balance sheet once the biosynthesized CBD isolate is ready to sell as a product Experienced research team … Continue reading “Willow Biosciences Inc. (CSE: WLLW) is “One to Watch””

CBDNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Enters Joint Development Agreement with Noramco Inc.

Willow Biosciences Inc. (CSE: WLLW), a leading developer of biosynthetic production systems for plant-derived active pharmaceutical ingredients (APIs) and intermediates, in early June announced its entry into an exclusive joint development agreement with Noramco Inc., a leading manufacturer of cannabinoids. Per the update, the two firms intend to collaboratively develop a yeast-based biosynthesis platform for … Continue reading “CBDNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Enters Joint Development Agreement with Noramco Inc.”

Willow Biosciences Inc. (CSE: WLLW) Enters Agreement with Noramco Inc. for Biosynthesis Platform

Willow has entered a joint development agreement with Noramco Inc. that includes a plan to develop a yeast-based biosynthesis platform to produce low-cost CBD for the pharmaceutical, food, beverage and personal care markets The agreement has the potential to open the door to new and larger markets for CBD and related compounds Terms of the … Continue reading “Willow Biosciences Inc. (CSE: WLLW) Enters Agreement with Noramco Inc. for Biosynthesis Platform”

How to Make CBD Oil Work Faster

If you’ve been paying attention to the news for the past few years, you have undoubtedly heard of cannabidiol (CBD), even in passing. Even before the 2018 Farm Bill legalized the cultivation and sale of hemp and its extracts, including CBD, the hemp extract was demanding attention due to its medicinal properties. Little research has … Continue reading “How to Make CBD Oil Work Faster”

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722